Ireland
--:--IST
Active, not recruiting Not applicable

Clinical Performance of All-ceramic Posterior Crowns. A Randomized, Prospective Clinical.

NCT04272112 · tracked via the Priya Life Science Sweden tracker
Phase
Not applicable
Started
2017-02-01
Last updated
2026-05-13

Condition(s) studied

Dental Prosthesis Failure

Investigational drug(s) / intervention(s)

IPS e.max CAD, Ivoclar VivadentBruxZir, GlidewellBruxZir*, Glidewell

IPS e.max CAD, Ivoclar Vivadent: Type: monolithic lithium-disilicate glass ceramic

BruxZir, Glidewell: Type: high translucent zirconia

BruxZir*, Glidewell: Type: high translucent zirconia with a mini-veneer of porcelain

Study summary

This is a randomized, prospective clinical trial. The aim of the project is to assess the clinical performance of three types of tooth-supported crowns; monolithic high translucent colored zirconia, crowns of high-translucent colored zirconia with a mini-veneer buccally and crowns of lithium-disilicate glass-ceramic. Crowns will be placed on posterior teeth and evaluated from an esthetic and functional point of view, to identify if there are any differences between the materials.

Eligibility

Sex
ALL
Min age
18 Years
Max age
—
Healthy volunteers
Accepted
Inclusion criteria: * need of one or more dental crowns in the posterior dentition, premolars and molars Exclusion criteria: * high caries activity/risk for caries and/or advanced periodontal disease

Primary outcome measure(s)

  • Clinical perfomance — 12 month
    To identify if there are any differences between the materials. The marginal integrity and surface will be rated as excellent, acceptable, retrievable or not acceptable according to a modified California Dental Association (CDA) quality assessment system.
  • Clinical perfomance — 24 month
    To identify if there are any differences between the materials. The marginal integrity and surface will be rated as excellent, acceptable, retrievable or not acceptable according to a modified California Dental Association (CDA) quality assessment system.
  • Clinical perfomance — 36 month
    To identify if there are any differences between the materials. The marginal integrity and surface will be rated as excellent, acceptable, retrievable or not acceptable according to a modified California Dental Association (CDA) quality assessment system.
  • Clinical perfomance — 60 month
    To identify if there are any differences between the materials. The marginal integrity and surface will be rated as excellent, acceptable, retrievable or not acceptable according to a modified California Dental Association (CDA) quality assessment system.
  • Clinical performance — 120 months
    To identify if there are any differences between the materials. The marginal integrity and surface will be rated as excellent, acceptable, retrievable or not acceptable according to a modified California Dental Association (CDA) quality assessment system.

Trial sites (1)

FacilityCityRegionStatus
Malmö University Malmö Sweden

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT04272112 on ClinicalTrials.gov ↗ ← All trials in Sweden